- Home
- DRUG
as 07-26-2024 4:00pm EST
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
| Founded: | 2019 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 5.0M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 44.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.98 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.93 - $6.44 | Next Earning Date: | 08-14-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Bright Minds Biosciences Inc. News
DRUG Breaking Stock News: Dive into DRUG Ticker-Specific Updates for Smart Investing
CNW Group
2 months ago
Start Proud Opens the Market
Associated Press Finance
2 months ago
Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it
Business Wire
2 months ago
Form 8.3 - Darktrace plc
Investor's Business Daily
2 months ago
Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives
Yahoo Finance Video
2 months ago
May jobs reports signals Fed's soft landing: US Labor Secretary
PR Newswire
2 months ago
Notification of major holding in Kindred Group plc
Business Wire
2 months ago
NICE to Webcast Financial Analyst and Investor Day at Interactions 2024
Business Wire
2 months ago
Form 8.3 - DS Smith plc
Compare DRUG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DRUG Bright Minds Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.